AU1874499A - A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane forintramuscular administration - Google Patents
A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane forintramuscular administrationInfo
- Publication number
- AU1874499A AU1874499A AU18744/99A AU1874499A AU1874499A AU 1874499 A AU1874499 A AU 1874499A AU 18744/99 A AU18744/99 A AU 18744/99A AU 1874499 A AU1874499 A AU 1874499A AU 1874499 A AU1874499 A AU 1874499A
- Authority
- AU
- Australia
- Prior art keywords
- forintramuscular
- bispiperidinylandrostane
- monoquaternary
- administration
- pharmaceutical formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97203713 | 1997-11-27 | ||
| EP97203713 | 1997-11-27 | ||
| PCT/EP1998/007519 WO1999027914A1 (en) | 1997-11-27 | 1998-11-23 | A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane for intramuscular administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1874499A true AU1874499A (en) | 1999-06-16 |
Family
ID=8228981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU18744/99A Abandoned AU1874499A (en) | 1997-11-27 | 1998-11-23 | A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane forintramuscular administration |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1874499A (en) |
| WO (1) | WO1999027914A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1239884T3 (en) * | 1999-12-22 | 2007-08-06 | Glaxo Group Ltd | Methods for preparing pharmaceutical formulations |
| US6911455B2 (en) | 1999-12-22 | 2005-06-28 | Smithkline Beecham Corporation | Methods for preparing pharmaceutical formulations |
| KR102060160B1 (en) * | 2013-07-01 | 2019-12-27 | 마루이시세이야쿠가부시키가이샤 | Rocuronium preparation with improved vascular pain, method for producing same, and method for suppressing and relieving vascular pain using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5418226A (en) * | 1992-04-22 | 1995-05-23 | Akzo N.V. | Monoquaternary 2,16-bispiperidinylandrostane derivatives |
| US5721215A (en) * | 1996-03-20 | 1998-02-24 | Allergan | Injectable therapy for control of muscle spasms and pain related to muscle spasms |
-
1998
- 1998-11-23 AU AU18744/99A patent/AU1874499A/en not_active Abandoned
- 1998-11-23 WO PCT/EP1998/007519 patent/WO1999027914A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999027914A1 (en) | 1999-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5402296A (en) | Pharmaceutical composition for transdermic administration | |
| AU6995396A (en) | Pharmaceutical formulation | |
| AU7305594A (en) | Physiologically active substance-prolonged releasing-type pharmaceutical preparation | |
| AU7499096A (en) | Stable freeze-dried pharmaceutical formulation | |
| AU7572196A (en) | Pharmaceutical formulations | |
| ZA965368B (en) | A pharmaceutical formulation | |
| AU7375598A (en) | Stable oral pharmaceutical dosage forms | |
| AU6534894A (en) | Drug administration system | |
| AU6973396A (en) | Pharmaceutical formulation | |
| HUP0001494A3 (en) | 3-phenoxy-, 3-dibenzo[a,d]cycloheptenyloxy-, 3-dibenz[b,f][1,4]oxazepinyloxy-1-amino-2-propanol derivatives and pharmaceutical compositions containing them | |
| ZA96124B (en) | A pharmaceutical formulation | |
| AU7588696A (en) | Pyrido{2, 3-D} pyrimidine derivatives and pharmaceutical compositions thereof | |
| AU1689999A (en) | Medicinal composition for percutaneous administration | |
| AU1827799A (en) | Oral delivery formulation | |
| AU6309698A (en) | Drugs containing aminopyridine derivatives as the active ingredient | |
| AU3453897A (en) | Medicinal cyclosporin-a aerosol solution formulation | |
| AU7582696A (en) | Pharmaceutical formulation | |
| AU2080695A (en) | Pharmaceutical inhalation compositions containing a solid active ingredient | |
| AU3055099A (en) | A pharmaceutical formulation for nasal administration | |
| AU3949093A (en) | A pharmaceutical formulation | |
| AU1874499A (en) | A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane forintramuscular administration | |
| AU5347996A (en) | Preparation for oral administration | |
| AU1475595A (en) | Pharmaceutical preparation | |
| ZA964372B (en) | A pharmaceutical formulation | |
| ZA965367B (en) | A pharmaceutical formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |